Treatment Landscape of Targeted Therapies in Oncology

Prof. Pawan Kumar Maurya is the Dean of the School of Lifelong Learning and Head of the Department of Biochemistry at the Central University of Haryana, India. He earned his Ph.D. from the University of Allahabad (a Central University), India, and completed postdoctoral training at Universidade Federal de São Paulo (UNIFESP), Brazil; Taipei Medical University (TMU); and National Taiwan University (NTU), Taiwan.With over 14 years of teaching and research experience, Prof. Maurya specializes in biochemical diagnostics, nanomedicine, and clinical biochemistry. He has published more than 75 research articles in leading journals and has edited six books with Elsevier (USA) and Springer Nature (Singapore).He is the recipient of prestigious fellowships, including Science Without Borders (Government of Brazil) and the National Science Council (Taiwan).Dr. Vikas Saini is working as an Assistant professor and Coordinator of Biomedical Sciences program under Department of Vocational Studies and Skill Development, Central University of Haryana, India. His area of interest is Cancer biology and drug discovery. He earned his Ph.D. in biomedical Sciences from Dr. B.R. Ambedkar Centre for Biomedical Research (ACBR), University of Delhi with an emphasis on identifying novel anticancer molecules. He has research experiences in the area of cheminformatics, drug synthesis, and cancer biology. He has more than 4 years of teaching experience and published several research articles and book chapters in reputed journals. He is currently working on testing novel compounds against cancer.

• 1. Preface2. Biology of Cancer: Current Insights and Perspectives3. Evolution of Targeted Therapies in Cancer: Opportunities and Challenges4. Clinical Implementations of Novel Targeted Therapeutics in Advanced Breast Cancer5. Targeted Therapies in Advanced Lung Cancer: Current Landscape And Future Projects6. Targeted Therapies: Emerging Biomarkers in Advanced Melanoma7. Targeted Therapies in Hematological Malignancies8. Glioblastoma Targeted Therapies: Updated Approaches from Recent Biological Insights9. Current Trends and Future Prospects of Molecular Targeted Therapy in Head And Neck Squamous Carcinoma10. Progress and Current Status of Targeted Therapy and Drug Resistance in Gastric and Pancreatic Cancer11. Colorectal Cancer Heterogenity and Targeted Therapy: Clinical Implications, Challenges and Solutions for Treatment Resistance12. Endometrial Cancer: Molecular Markers and Management of Advanced Stage Disease13. Bibliography14. Glossary